Laughing_cow said:
freedbondage said:
Yet another denial from a health insurer. With coverage for glp-1 medications disappearing from plan after plan, that's the reality for a growing number of people. Meanwhile, Lilly seems puzzled that enrollment in their $500 per month savings card hasn't matched expectations...
I realize I'm telling this to people who already agree, but the whole situation is absurd. These medications could ease so many health issues. Since I wasn't diabetic or prediabetic, my plan wouldn't cover them. Through my bariatric doctor, I got a month of Victoza for 4 dollars. Officially it was self-pay, though the doctor had a grant. When that grant ran out, Ozempic became the cheaper option and offered a monthly payment plan, so I paid 100 each month (my dose was low, so one 2ml pen stretched further for me). That program also came to an end, and I can't move to a higher dose since 400 a month doesn't fit my budget.
My mother, though, was prediabetic, and neither of us responded as quickly as many others do. Ozempic brought her H1C down, which is good, but her provider wouldn't change her to Mounjaro and judged her for wanting to shed weight (she was around 315). So she found a different provider willing to prescribe it, and she's now in the 250s. Luckily she still has coverage, but they're now pushing to reduce her dose because her H1C looks good. So if everything works out with grey, I think I'll assist her as well, since these drugs have done so much for her.
Slightly off-topic, but I wonder whether genetics play a role in how people react to GLP-1s. My mother, my cousin on my maternal side, and I all responded less strongly to semaglutide than others did, and we never saw fast weight loss. It certainly helped, but my 70 lb loss took over 2 years, while some people drop 40 lbs in 3 months.
